Cell Signaling Technology Logo
1% for the planet logo
Trial Size Available Flag
Recombinant Flag
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

NPTX2 (F6B1F) Rabbit mAb #16967

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 60, 50
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:200

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    NPTX2 (F6B1F) Rabbit mAb recognizes endogenous levels of total NPTX2 protein. This antibody does not cross-react with other NPTX proteins.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human NPTX2 protein.

    Background

    The neuronal pentraxin (NPTX) family is composed of two secreted proteins, neuronal pentraxin 1 (NPTX1) and 2 (NPTX2), along with the NPTX receptor (NPTXR), a type II transmembrane protein. These proteins are part of the larger, evolutionarily conserved pentraxin superfamily. NPTX1, NPTX2, and NPTXR are known as long pentraxins. They share a conserved C-terminal domain with the short pentraxin family, which consists of C-reactive protein (CRP) and serum amyloid P component (SAP), but they differ in that they also have unique, long N-terminal sequences containing low complexity regions. NPTXs play vital roles in synaptogenesis, synaptic pruning and plasticity, debris clearance, and neurite outgrowth (1-4). NPTX1 and NPTX2 are primarily secreted at presynaptic terminals of excitatory neurons. Once secreted into the synaptic cleft, they form homo or hetero-oligomers via their C-terminal pentraxin domains and bind NPTXR on the postsynaptic membrane. This complex then acts to cluster α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), modulating synaptic activity and neuronal function (3,4). Synaptic dysfunction and neuronal loss are hallmarks of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and frontotemporal lobar degeneration (FTLD). Expression levels of NPTX family members in the brain, cerebrospinal fluid (CSF), and plasma have been shown to be altered in AD, PD, and FTLD, suggesting that they may be markers for this dysfunction, as well as diagnostic and therapeutic targets for these diseases (3,5-7). NPTX2 expression can also be regulated by TAR DNA-binding protein 43 (TDP43), suggesting a possible link to TDP43 dysfunction and related proteinopathies such as FTLD and amyotrophic lateral sclerosis (ALS) (8).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.